The Company granted 214,526 awards to employees under the 2016 Amended and Restated Incentive Award Plan during the nine months ended September 30, 2026, consisting of 111,158 RSU and 58,368 stock options having five year vesting schedules and 15,000 RSU and 30,000 stock options having two year vesting schedules. The Company granted an additional 6,660 stock option awards to non-employee directors under the 2016 Amended and Restated Incentive Award Plan during the nine months ended September 30, 2026. These awards are scheduled to vest on the earlier of (a) the day immediately preceding the date of the first annual meeting following the date of grant and (b) the first anniversary of the date of grant, subject to the non-employee director continuing in service through the applicable vesting date.


	Nine Months Ended September 30, 2026
	Stock Options	Weighted Average Exercise Price
Outstanding - beginning of period	618,681	$	211.29
Granted	95,028	$	414.20
Exercised	(183,475)	$	140.22
Cancelled/Forfeited/Expired	(11,643)	$	331.92
Outstanding - end of period	518,591	$	271.17

Exercisable - end of period	377,943	$	225.74


			Nine Months Ended September 30, 2026
			Shares/Units
Outstanding and unvested - beginning of period			324,517
Granted			126,158
Vested			(118,335)
Forfeited			(26,285)
Outstanding and unvested - end of period			306,055

Stock-based compensation expense recognized in the condensed consolidated statements of operations related to all outstanding stock-based compensation awards is summarized below (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Total direct costs	$	3,306	$	3,772	$	9,121	$	10,219
Selling, general and administrative	4,298		2,551		7,749		18,947
Total stock-based compensation expense	$	7,604	$	6,323	$	16,870	$	29,166